MicroRNA-381 targets G protein-Coupled receptor 34 (GPR34) to regulate the growth, migration and invasion of human cervical cancer cells
- PMID: 33086148
- DOI: 10.1016/j.etap.2020.103514
MicroRNA-381 targets G protein-Coupled receptor 34 (GPR34) to regulate the growth, migration and invasion of human cervical cancer cells
Abstract
MicroRNAs (miRNAs) have emerged as the vital post-transcriptional regulators and control the growth and progression of different cancers types. The current study aimed at exploration of the role of microRNA-381 (miRNA-381) in human cervical cancer with emphasis on the evaluation of the underlying molecular mechanism. The results revealed a significant (P < 0.05) downregulation of miRNA-381 was found in cervical cancer tissues and cancer cell lines. Overexpression of miRNA-381 in cervical cancer cells significantly (P < 0.05) inhibited their proliferation through the induction of cell apoptosis which was accompanied by depletion of Bcl-2 and increase in Bax expression. Additionally, the cleavage of caspase-3 and 9 was also activated upon miRNA-381 overexpression. The Overexpression of miRNA-381 further inhibited the migration and invasion of cervical cancer cells. In silico analysis together with dual luciferase assay revealed G protein-Coupled receptor 34 (GPR34) to be the target of miRNA-381. The expression of GPR34 was significantly (P < 0.05) upregulated in the cervical cancer tissues and cell lines. Nonetheless, miRNA-381 overexpression caused a remarkable decrease in the expression of GPR34. The GPR34 knockdown and overexpression proved that the tumor-suppressive effects of miRNA-381 are mediated via GPR34. The study elucidated the essence of miRNA-381/GPR34 molecular regulatory axis in cervical cancer and unraveled the possibility of targeting this molecular axis as an important therapeutic approach against human cervical cancer.
Keywords: Apoptosis; Cell proliferation; Cervical cancer; Invasion; MicroRNA; Migration; Western blotting.
Copyright © 2020. Published by Elsevier B.V.
Similar articles
-
G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.Chin Med J (Engl). 2015 Feb 20;128(4):545-9. doi: 10.4103/0366-6999.151114. Chin Med J (Engl). 2015. PMID: 25673461 Free PMC article.
-
MicroRNA-300 Inhibits the Proliferation and Metastasis of Cervical Cancer Cells via Posttranscriptional Suppression of G Protein-Coupled Receptor 34 (GPR34).J Oncol. 2021 Dec 14;2021:2669822. doi: 10.1155/2021/2669822. eCollection 2021. J Oncol. 2021. PMID: 34950207 Free PMC article.
-
G-protein coupled receptor 34 regulates the proliferation and growth of LS174T cells through differential expression of PI3K subunits and PTEN.Mol Biol Rep. 2022 Apr;49(4):2629-2639. doi: 10.1007/s11033-021-07068-4. Epub 2022 Jan 8. Mol Biol Rep. 2022. PMID: 34997428 Free PMC article.
-
microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.Biochem Biophys Res Commun. 2016 Jun 24;475(2):169-75. doi: 10.1016/j.bbrc.2016.05.066. Epub 2016 May 13. Biochem Biophys Res Commun. 2016. PMID: 27181358
-
Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling.Life Sci. 2019 Oct 15;235:116785. doi: 10.1016/j.lfs.2019.116785. Epub 2019 Aug 21. Life Sci. 2019. PMID: 31445025
Cited by
-
GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC.Mediators Inflamm. 2025 Aug 18;2025:5576056. doi: 10.1155/mi/5576056. eCollection 2025. Mediators Inflamm. 2025. PMID: 40862294 Free PMC article.
-
Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer.Cancer Cell Int. 2023 Nov 25;23(1):294. doi: 10.1186/s12935-023-03152-w. Cancer Cell Int. 2023. PMID: 38007443 Free PMC article.
-
G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221105733. doi: 10.1177/15330338221105733. Technol Cancer Res Treat. 2022. PMID: 35770303 Free PMC article.
-
Cryo-EM structures of human GPR34 enable the identification of selective antagonists.Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2308435120. doi: 10.1073/pnas.2308435120. Epub 2023 Sep 21. Proc Natl Acad Sci U S A. 2023. PMID: 37733739 Free PMC article.
-
Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid.Cell Biochem Biophys. 2021 Sep;79(3):497-508. doi: 10.1007/s12013-021-00988-9. Epub 2021 Jun 15. Cell Biochem Biophys. 2021. PMID: 34129148 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials